|
2019
|
Invention
|
Compositions comprising enzyme-cleavable amphetamine prodrugs and inhibitors thereof. Pharmaceuti... |
|
2016
|
Invention
|
Compositions comprising enzyme-cleavable ketone-modified opioid prodrugs and optional inhibitors ... |
|
2015
|
Invention
|
Active agent prodrugs with heterocyclic linkers.
The embodiments provide prodrug compounds of Fo... |
|
|
Invention
|
Compositions comprising enzyme-cleavable opioid prodrugs and inhibitors thereof. Pharmaceutical c... |
|
|
Invention
|
Compositions comprising enzyme-cleavable oxycodone prodrug. The embodiments provide Compound KC-8... |
|
2014
|
Invention
|
Controlled release of phenolic opioids.
A method of providing a patient with controlled release ... |
|
|
Invention
|
Pharmaceutical compositions with attenuated release of phenolic opioids. Pharmaceutical compositi... |
|
|
Invention
|
Opioid prodrugs with heterocyclic linkers. The embodiments provide prodrug compounds of Formulae ... |
|
2012
|
Invention
|
Compositions comprising enzyme-cleavable prodrugs of active agents and inhibitors thereof.
The p... |
|
|
Invention
|
Compositions comprising enzyme-cleavable phenol-modified opioid prodrugs and inhibitors thereof. ... |
|
|
Invention
|
Controlled release of phenolic opioids. A method of providing a patient with controlled release o... |
|
|
Invention
|
Active agent prodrugs with heterocyclic linkers. The embodiments provide prodrug compounds of For... |
|
|
Invention
|
Compositions for reducing risk of adverse events caused by drug-drug interactions.
The present d... |
|
|
Invention
|
Compositions for reducing risk of adverse events caused by drug-drug interactions. The present di... |
|
|
Invention
|
Compositions comprising enzyme-cleavable oxycodone prodrug. The embodiments provide Compound KC-7... |
|
2011
|
Invention
|
Peripheral opioid agonists and peripheral opioid antagonists.
The present disclosure provides co... |
|
|
Invention
|
Compositions comprising enzyme-cleavable amphetamine prodrugs and inhibitors thereof.
Pharmaceut... |
|
|
Invention
|
Peripheral opioid agonists and peripheral opioid antagonists. The present disclosure provides com... |
|
2010
|
Invention
|
Compositions comprising enzyme-cleavable hydromorphone prodrug.
The embodiments provide Compound... |
|
|
Invention
|
Compositions comprising enzyme-cleavable phenol-modified tapentadol prodrug. A method of providin... |
|
|
Invention
|
Compositions comprising enzyme-cleavable hydromorphone prodrug. The embodiments provide Compound ... |
|
|
Invention
|
Compositions comprising enzyme-cleavable opioid prodrugs and inhibitors thereof. The present disc... |
|
|
Invention
|
Compositions comprising enzyme-cleavable opioid prodrugs and inhibitors thereof.
Pharmaceutical ... |
|
|
Invention
|
Compositions comprising enzyme-cleavable prodrugs of active agents and inhibitors thereof. The pr... |
|
2009
|
Invention
|
Analogs of propofol, preparation thereof and use as anesthetics.
Compounds of formula (I) wherei... |
|
|
Invention
|
Anesthetic compounds.
The invention provides novel phenolic ester local anesthetic compounds. Th... |
|
2008
|
Invention
|
Peripheral phenolic opioid antagonist.
N-Methyldiprenorphine, useful as an opioid antagonist. |
|
|
Invention
|
N-17-alkylated prodrugs of opioids.
Compounds of formula (II) R1R2R3N+—(C(R1a)(R2a))—Ar—Z—C(O)—Y... |
|
|
Invention
|
Prodrugs of peripheral phenolic opioid antagonists.
Compounds of formula (I)
in which X, ... |
